BioPharma Dive February 13, 2023
Sponsored content By By Qiagen

Introducing a new way to improve bioinformatics efficiency in high-throughput NGS settings

It’s exciting that advancements in high-throughput sequencing techniques and analysis enable us to generate whole genome (WGS) and whole exome (WES) data in bulk for many species, including humans. With new machines and chemistries, the cost of sequencing has decreased significantly. However, the total cost of ownership associated with bioinformatic analysis of the resulting files remains a bottleneck.1

Whether you run a genome center, testing facility, core lab or provide sequencing services, you’ve got to deliver variant call files (VCFs) at an unbeatable price and with consistent quality and turnaround time, even at peak demand. Your customers, as well as your business, depend on it. Many high-speed NGS...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article